NITRASE THERAPEUTICS
Nitrase Therapeutics is a platform company developing drugs against a newly identified class of enzymes called Nitrases, initially targeting Parkinson’s disease. The therapies that Nitrome is developing will target these enzymes and potentially help slow or halt the progression of diseases such as Parkinson’s. While the initial focus is on Parkinson's disease, the company aims to expand its proprietary platform to include other disease indications.
NITRASE THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
Jackson, Mississippi, United States
Country:
United States
Website Url:
http://www.nitrasetx.com
Total Employee:
1+
Status:
Active
Contact:
4153101058
Total Funding:
45.1 M USD
Technology used in webpage:
Google Maps
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Be Biopharma
Be Biopharma is developing B ceaBe Biopharma is a biotech research company that develops a class of B cells as medicines.lls as medicines.
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
Dementia Discovery Fund
Dementia Discovery Fund investment in Series A - Nitrase Therapeutics
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series A - Nitrase Therapeutics
Bristol Myers Squibb
Bristol Myers Squibb investment in Series A - Nitrase Therapeutics
Sofinnova Partners
Sofinnova Partners investment in Series A - Nitrase Therapeutics
Mission Bay Capital
Mission Bay Capital investment in Series A - Nitrase Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Nitrase Therapeutics
Mission Bay Capital
Mission Bay Capital investment in Series A - Nitrase Therapeutics
Sofinnova Partners
Sofinnova Partners investment in Series A - Nitrase Therapeutics
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series A - Nitrase Therapeutics
Dementia Discovery Fund
Dementia Discovery Fund investment in Series A - Nitrase Therapeutics
Official Site Inspections
http://www.nitrasetx.com Semrush global rank: 5.7 M Semrush visits lastest month: 1.47 K
- Host name: 170.6.212.35.bc.googleusercontent.com
- IP address: 35.212.6.170
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Nitrase Therapeutics"
Home - Nitrase Therapeutics
Our proprietary NITROME Platform leverages our unique knowledge of protein nitration to unlock the full therapeutic potential of nitrases by identifying novel nitrases, their nitro-substrates and …See details»
About - Nitrase Therapeutics
Our wholly-owned first-in-class enzyme therapeutics platform is based on Nitrome’s novel scientific discoveries. We have cracked the code on key disease pathology in neurodegenerative and inflammatory diseases.See details»
Overview - Nitrase Therapeutics
Nitrase Therapeutics is a leading biopharmaceutical company deploying its unique NITROME platform to unlock the therapeutic potential of nitrases, a new class of enzymes discovered in-house that offer the promise of a pipeline of …See details»
Nitrase Therapeutics - Crunchbase Company Profile & Funding
View contacts for Nitrase Therapeutics to access new leads and connect with decision-makers. Nitrase Therapeutics is a platform company developing drugs against a newly identified class …See details»
Nitrase Therapeutics - LinkedIn
At Nitrase, we are developing our unique NITROME platform to unlock the therapeutic potential of nitrases, a new class of enzymes with the potential to treat cancer and other diseases. Learn more...See details»
Director Of Operations at Nitrase Therapeutics - The Org
Carla Ramos has a diverse work experience in the pharmaceutical industry spanning over two decades. Carla most recently served as the Director Of Operations at Nitrase Therapeutics since September 2020.See details»
Nitrase Therapeutics Presented Data on Role of Novel
BRISBANE, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Nitrase Therapeutics, Inc., a biopharmaceutical company deploying its NITROME platform to build a pipeline of therapies …See details»
Nitrome Biosciences Appoints Pierre Beaurang, Ph.D., as Chief …
San Francisco, CA – November 2, 2021 – Nitrase Therapeutics, Inc. (formerly Nitrome Biosciences), a biopharmaceutical company deploying its unique NITROME platform to unlock …See details»
Nitrase Therapeutics Receives New Grant from The Michael J.
Apr 5, 2022 · For more information, please visit the company’s website at www.nitrasetx.com. As the world's largest nonprofit funder of Parkinson's research, The Michael J. Fox Foundation is …See details»
Nitrase Therapeutics Expands Pipeline to Include Oncology
Jun 2, 2022 · For more information, please visit the company’s website at www.nitrasetx.com. Discovery of several nitrases that play an oncogenic role in both solid and hematological …See details»
Mission - Nitrase Therapeutics
We exist to elucidate the biology of nitrases, their link to diseases and to create novel medicines targeting this enzyme pathway. The company’s mission is to deliver on the vast potential of its …See details»
History - Nitrase Therapeutics
Nitrase Therapeutics was founded by Irene Griswold-Prenner, Ph.D., our Chief Executive Officer. By exploring the biological mechanism that led to the death of neurons in Parkinson’s disease, …See details»
Nitrase Therapeutics Announces Presentation at the SFN
BRISBANE, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Nitrase Therapeutics, Inc., a biopharmaceutical company deploying its NITROME platform to build a pipeline of therapies …See details»
Nitrase Biosciences | VentureRadar
Website: https://nitrasetx.com/ Develops the NITROME platform, leveraging unique knowledge of protein nitration to identify novel nitrases and deliver innovative disease therapeutics. …See details»
Nitrase Therapeutics - Overview, News & Similar companies
Dec 11, 2022 · View Nitrase Therapeutics (www.nitrasetx.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Careers - Nitrase Therapeutics
We are seeking inquisitive individuals who can thrive in a collaborative and dynamic culture and are steadfast in the commitment to advance cutting-edge science to make transformative …See details»
Nitrase Therapeutics, Inc. | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Nitrome Biosciences Appoints Pierre Beaurang, Ph.D., as
Nov 2, 2021 · Nitrase Therapeutics is a pioneering biopharmaceutical company deploying its unique NITROME platform to unlock the therapeutic potential of nitrases, a new class of …See details»
Nitrase Therapeutics Presented Data on the Importance of
Nov 14, 2022 · Nitrase Therapeutics is a pioneering biopharmaceutical company deploying its unique NITROME platform to unlock the therapeutic potential of nitrases, a new class of …See details»
Breakthrough Platform - Nitrase Therapeutics
Our proprietary NITROME Platform leverages our unique knowledge of protein nitration to unlock the full therapeutic potential of nitrases by identifying novel nitrases, their nitro-substrates and …See details»